⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29910731 | 1.00 | — | — | |
| SCHEMBL10692642 | 0.74 | — | — | |
| SCHEMBL30121690 | 0.74 | — | — | |
| SCHEMBL1576635 | 0.74 | — | — | |
| SCHEMBL30930706 | 0.74 | — | — | |
| SCHEMBL25214392 | 0.74 | — | — | |
| SCHEMBL2936869 | 0.74 | — | — | |
| SCHEMBL2646498 | 0.74 | — | — | |
| SCHEMBL30812605 | 0.74 | — | — | |
| SCHEMBL18038723 | 0.72 | CHRNB2 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 972 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118005615-A | Pyridazine compound and preparation method, pharmaceutical composition and application thereof | 中国药科大学 | 2024-05-10 | — | — | CN | claimed |
| CN-116082110-B | The method comprises the following steps of 11 C-labeled targeted anaplastic lymphoma kinase ALK mutant molecular probe and application thereof | 北京肿瘤医院(北京大学肿瘤医院) | 2024-04-12 | — | — | CN | claimed |
| CN-117756729-A | Preparation method of deuterium-celecoxib and intermediate thereof | 上海鼎雅药物化学科技有限公司 | 2024-03-26 | — | — | CN | claimed |
| CN-116082110-A | The method comprises the following steps of 11 C-labeled targeted anaplastic lymphoma kinase ALK mutant molecular probe and application thereof | 北京肿瘤医院(北京大学肿瘤医院) | 2023-05-09 | — | — | CN | claimed |
| CN-104402828-A | Synthetic method of 3-amino-4-bromo-6-chlorodiazine | DINGTAO COUNTY YOUBANG CHEMICAL INDUSTRY CO LTD | 2015-03-11 | — | — | CN | claimed |
| WO-2026107406-A1 | p53 HETEROBIFUNCTIONAL CONJUGATES AND USES THEREOF | Design Therapeutics, Inc. (US) | 2026-05-21 | — | — | WO | disclosed |
| US-20260138956-A1 | NOVEL COMPOUNDS AND USES THEREOF | RECURSION PHARMACEUTICALS INC (US) | 2026-05-21 | — | — | US | disclosed |
| WO-2026098598-A1 | COMPOUND CONTAINING THREE FUSED HETEROCYCLIC RINGS | 正大天晴药业集团股份有限公司 | 2026-05-15 | — | — | WO | disclosed |
| CN-122036699-A | THR-beta modulators and methods of use thereof | 阿利戈斯治疗公司 | 2026-05-15 | — | — | CN | disclosed |
| US-12624044-B2 | SMARCA degraders and uses thereof | KYMERA THERAPEUTICS, INC. (US) | 2026-05-12 | — | — | US | disclosed |
| EP-4727541-A2 | COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THAT DEGRADE SWI/SNF-RELATED MATRIX-ASSOCIATED ACTIN-DEPENDENT REGULATOR OF CHROMATIN SUBFAMILY A | Plexium, Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| EP-4727543-A2 | COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THAT DEGRADE SWI/SNF-RELATED MATRIX-ASSOCIATED ACTIN-DEPENDENT REGULATOR OF CHROMATIN SUBFAMILY A | Plexium, Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| WO-2007013673-A1 | FUSED HETEROCYCLES AS LCK INHIBITORS | ASTELLAS PHARMA INC. (JP) | 2007-02-01 | — | — | WO | disclosed |
| US-20060211696-A1 | IMIDAZO[1,2-b]PYRIDAZINE COMPOUND | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2006-09-21 | — | — | US | disclosed |
| US-20060189613-A1 | Sulphonamide Compounds that Modulate Chemokine Receptor Activity (CCR4) | ASTRAZENECA AB (SE) | 2006-08-24 | — | — | US | disclosed |
| US-7078405-B2 | Imidazo[1,2-b]pyridazine compound | EISAI CO., LTD. (JP) | 2006-07-18 | — | — | US | disclosed |
| EP-1633723-A1 | SULPHONAMIDE COMPOUNDS THAT MODULATE CHEMOKINE RECEPTOR ACTIVITY (CCR4) | AstraZeneca AB (SE) | 2006-03-15 | — | — | EP | disclosed |
| WO-2004108690-A1 | SULPHONAMIDE COMPOUNDS THAT MODULATE CHEMOKINE RECEPTOR ACTIVITY (CCR4) | ASTRAZENECA AB (SE) | 2004-12-16 | — | — | WO | disclosed |
| US-20040082781-A1 | Bicyclic nitrogenous fused-ring compound | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2004-04-29 | — | — | US | disclosed |
| EP-1364952-A1 | BICYCLIC NITROGENOUS FUSED-RING COMPOUND | Eisai Co., Ltd. (JP) | 2003-11-26 | — | — | EP | disclosed |